FDA pulls pain medication Darvon & Darvocet from market

The U.S. Food and Drug Administration report that Xanodyne Pharmaceuticals Inc., manufacturer of Davon and Darvocet, has agreed to pull the two pain medication from the market due to risk of potentially serious or fatal side effects including heart rhythm abnormalities and also because of concerns that too many patients have overdosed on the drug.
seattle propoxyphene darvon attorney
Darvon and Darvocet has been prescribed to 10 million people since 2009.

The FDA says that intentional or unintentional overdoses can occur when the drug is taken by itself or with alcohol or other medications.

Davon and Darvocet have been linked to more than 2,000 deaths in the past 30 years. Both medications contain propoxyphene which can be habit forming.

The FDA has asked generic makers of the medical to pull their drugs as well.

Many people feel that this decision is a long time in coming; the UK pulled the medication off of the market in 2005 and Europe’s medical regulator removed it from that market in 2009.

This information is provided by Washington Injury Attorney blog, a service of The Farber Law Group. We represent people who have been seriously injured in due to dangerous and defective products and the family of those who have died. For information about your legal rights, contact The Farber Law Group today.

Related Posts:

FDA says generic Tamiflu may contain dangerous ingredients

Group asks FDA to pull Ortho Evra birth control patch from market due to blood clot risk

Jury awards Accutane user $7 million because of inflammatory bowel disease https://www.seattlecaraccidentlawyerblog.com/

Contact The Farber Law Group at 1-800-244-9087 or attorney@hgfarber.com to schedule a free and confidential case evaluation. We have offices in Seattle and Bellevue to assist you.

For current articles relating to motor vehicle accidents, see Seattle Car Accident Lawyer blog, which is also presented by The Farber Law Group.